These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39009082)

  • 1. Comparison of galactomannan lateral flow assay and enzyme immunoassay to identify Aspergillus spp. in bronchoalveolar lavage fluid.
    Martins SC; Tararam CA; Levy LO; Arai T; Watanabe A; Moretti ML; Trabasso P
    Braz J Infect Dis; 2024; 28(4):103838. PubMed ID: 39009082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Aspergillus galactomannan Ag VIRCLIA® Monotest and the sõna Aspergillus galactomannan lateral flow assay show comparable performance for the diagnosis of invasive aspergillosis.
    Küpper C; Erb TM; Träger J; Meintker L; Valenza G; Bogdan C; Held J
    Mycoses; 2024 Aug; 67(8):e13782. PubMed ID: 39109555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid.
    Husain S; Clancy CJ; Nguyen MH; Swartzentruber S; Leather H; LeMonte AM; Durkin MM; Knox KS; Hage CA; Bentsen C; Singh N; Wingard JR; Wheat LJ
    Clin Vaccine Immunol; 2008 Dec; 15(12):1760-3. PubMed ID: 18845830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different lateral flow assays on bronchoalveolar lavage fluid for invasive aspergillosis screening in non-hematological patients.
    Devillers E; Scherer E; Navellou JC; Grenouillet F; Millon L; Bellanger AP
    J Mycol Med; 2024 Jun; 34(2):101481. PubMed ID: 38718721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative performance of the Platelia
    Albert E; Alcaraz MJ; Giménez E; Clari MÁ; Torres I; Colomina J; Olea B; Tormo M; Piñana JL; Oltra R; Signes-Costa J; Carbonell N; Solano C; Navarro D
    Microbiol Spectr; 2024 Aug; 12(8):e0391023. PubMed ID: 38916338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
    Serin I; Dogu MH
    Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.
    Sedik S; Boyer J; Egger M; Dichtl K; Prattes J; Prüller F; Hoenigl M
    Mycopathologia; 2024 Jul; 189(4):67. PubMed ID: 39023825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the Aspergillus galactomannan lateral flow assay with a digital reader for the diagnosis of invasive aspergillosis: a multicenter study.
    Guo J; Xiao C; Tian W; Lv L; Hu L; Ni L; Wang D; Li W; Qiao D; Wu W
    Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):249-257. PubMed ID: 38030860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
    Scharmann U; Verhasselt HL; Kirchhoff L; Buer J; Rath PM; Steinmann J; Ziegler K
    Mycoses; 2020 Dec; 63(12):1362-1367. PubMed ID: 32885514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Performance of Two Galactomannan Detection Tests: Platelia Aspergillus Ag and Aspergillus Galactomannan Ag Virclia Monotest.
    Calero AL; Alonso R; Gadea I; Vega MDM; García MM; Muñoz P; Machado M; Bouza E; García-Rodríguez J
    Microbiol Spectr; 2022 Apr; 10(2):e0262621. PubMed ID: 35262395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
    J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
    Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
    Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
    Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
    Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis.
    Wiederhold NP; Thornton CR; Najvar LK; Kirkpatrick WR; Bocanegra R; Patterson TF
    Clin Vaccine Immunol; 2009 Dec; 16(12):1844-6. PubMed ID: 19793899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens.
    Wheat LJ; Nguyen MH; Alexander BD; Denning D; Caliendo AM; Lyon GM; Baden LR; Marty FM; Clancy C; Kirsch E; Noth P; Witt J; Sugrue M; Wingard JR
    J Clin Microbiol; 2014 Jun; 52(6):2108-11. PubMed ID: 24719449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.